Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0LJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,300
Award facts
- Contract value 100% obligated
- $16,300.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,300.39 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor, fulfills critical medical procurement needs for federal agencies, particularly military and veteran healthcare systems, through its extensive portfolio of brand-name and generic medications, vaccines, and medical devices. The Zepbound order represents part of the contractor's ongoing support of federal medical supply chains, demonstrating its capability to meet government requirements for specialized pharmaceutical products across multiple therapeutic domains. This contract supports the DLA's medical supply chain operations and the broader Defense Health Agency mission to provide essential medications to military treatment facilities and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FR0LJ?
SPE2DR26FR0LJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FR0LJ worth?
The government has obligated $16,300 on SPE2DR26FR0LJ.
Is contract SPE2DR26FR0LJ an order under another contract?
Yes. SPE2DR26FR0LJ is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0LJ competed?
The extent of competition for SPE2DR26FR0LJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award